市场调查报告书
商品编码
1422077
全球膝关节置换市场评估:依手术类型、植入物类型、最终用户、地区、机会和预测(2017-2031)Knee Replacement Market Assessment, By Procedure Type, By Implant Type, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
全球膝关节置换市场总规模预计将从 2023 年的 101 亿美元增至 2031 年的 153.6 亿美元,在 2024-2031 年预测期内复合年增长率为 5.38%。 全膝关节置换术(也称为膝关节置换术)是一种使用金属、塑胶或陶瓷植入物来纠正膝关节损伤的外科手术。 这些手术旨在减轻膝盖受伤引起的疼痛和痛苦。 由于关节炎等与年龄相关的膝盖疾病,老年人经常接受此类手术。
由于膝骨关节炎的盛行率不断增加,全膝关节置换市场正在呈现成长。 最容易受到膝关节损伤的老年人口不断增长,推动了全膝关节置换手术的需求。 此外,微创手术和全膝关节置换术中使用的植入物的技术进步保持了市场持续扩张的趋势。 世界各地膝骨关节炎和膝关节相关损伤的流行增加了全膝关节置换手术的需求。 全膝关节置换手术在 55 岁及以上的人群中很常见,世界各地老年人口的不断增长,特别是在日本和美国等国家,进一步推动了市场的成长。
根据 OECD 数据,平均每 10 万人中有 174 例髋关节置换术和 137 例膝关节置换术。 瑞士和芬兰等欧洲国家在经合组织国家中进行的全膝关节置换手术数量最多。
膝骨关节炎的高盛行率对于全膝关节置换市场的扩大至关重要。 骨关节炎影响骨关节,大多数病例涉及膝关节。 55岁以上的女性更容易罹患骨关节炎。 老年人因骨骼退化和滑液流失而患有骨关节炎,而女性则患有缺钙症。 根据最近的估计和预测,预计骨关节炎病例在预测年内将会增加。
例如,根据世界卫生组织2023年7月发布的情况说明书,全球有超过5.28亿人患有骨关节炎,其中约3.65亿人的膝盖患有骨关节炎。相关病例需要全膝关节置换等解决方案。 这5.28亿人中大约73%是55岁以上的人,其中60%是女性。
植入物、微创手术和全膝关节置换手术领域的技术进步对全膝关节置换市场的成长做出了重大贡献。 精确的肢体对齐、改进的植入物定位精确度和植入物尺寸的进步使患者能够顺从。 手术机器人、人工智慧、3D 列印和电脑导航等工具可以帮助提供更好的膝关节置换术。 对准确性和精密度的需求正在推动製造商设计创新的解决方案,进一步促进市场成长。
例如,2023 年 10 月,Medacta Group S.A. 宣布推出 GMK SpheriKA,这是世界上第一个用于全膝关节置换术的运动学对准优化股骨组件。 Medacta Group S.A. 是一家总部位于瑞士的公司,为运动医学、关节置换和脊椎手术提供个人化、创新和永续的解决方案。
政府对研发的投资显着增强了全膝关节置换市场。 政府旨在透过改革医疗器材法规和为关节置换提供补贴来降低关节置换成本的措施正在显着推动市场成长。 此外,免税和与知名製造商的合作增加了国内产量并减少了对进口的依赖。 这些措施将提高全膝关节置换手术的可近性和可负担性,将某些国家确立为全膝关节置换市场的关键国家,并促进医疗保健领域的经济成长和创新。
例如,美国政府的关节置换综合护理 (CJR) 模式计划于 2024 年 12 月完成八个实施年 (PY)。 该计划是 Medicare A 部分和 B 部分支付模式,旨在为接受髋关节、膝关节和踝关节置换术(也称为下肢关节置换术)的患者提供融资。 该计划八年来取得了巨大成功,是政府努力支持全膝关节置换市场的一个很好的例子。
本报告研究和分析了全球全膝关节置换市场,提供市场规模和预测、市场动态、主要参与者趋势和前景等。
Global knee replacement market is projected to witness a CAGR of 5.38% during the forecast period 2024-2031, growing from USD 10.1 billion in 2023 to USD 15.36 billion in 2031. Knee replacement (also known as knee arthroplasty) is a surgical procedure to rectify knee damage using implants made of metal, plastic, or ceramics. These surgeries aim to relieve the pain and suffering caused by knee damage. The elderly population is the major recipient of such surgeries due to age-associated knee problems like arthritis.
The knee replacement market is experiencing growth due to the growing prevalence of osteoarthritis. The rising geriatric population, which is most prone to knee damage, is fueling the demand for knee replacements. Furthermore, technological advances in minimally invasive surgeries and implants used for knee replacements sustain a tendency for continual market expansion. The rising prevalence of osteoarthritis and knee-associated damage across the globe is increasing the demand for more knee replacement surgeries. Knee replacement surgeries are more common in old-age people above the age of 55 years, thus, the growing geriatric population globally and especially in countries like Japan and United States, further propelling the market growth.
As per OECD data, on average 174 hip replacements per 100,000 people, and 137 knee replacements per 100,000 people are being performed. European countries like Switzerland, Finland, and others are leading the number of knee replacements among OECD countries.
The high prevalence of knee-associated osteoarthritis is critical for the expansion of the knee replacement market. Osteoarthritis affects bone joints, and most of the cases are related to knee joints. People over the age of 55 years and female population are highly susceptible to osteoarthritis. The old age population is affected by osteoarthritis due to degenerative bones and reduced synovial fluid while females are affected because of calcium deficiency. As per recent estimates, osteoarthritis cases are expected to grow during the forecasted years.
For instance, according to the WHO factsheet published in July 2023, more than 528 million people are affected by osteoarthritis across the world, out of which around 365 million cases are knee-associated, which requires solutions like knee replacements. Around 73% of these 528 million cases are contributed by the population above the age of 55 years and 60% of these cases belong to female population.
Technological advancements in the field of implants, minimally invasive surgeries, and knee replacement solutions are major contributors to the growth of the knee replacement market. Advancements such as precise limb alignment, improved accuracy in implant positioning, and implant sizing are enabling patient compliance. Surgical robotics, artificial intelligence, 3D printing, and computer navigation are some of the tools that help in achieving better quality knee replacement solutions. The need for accuracy and precision is driving manufacturers to design innovative solutions, further enhancing market growth.
For example, in October 2023, Medacta Group S.A. announced the launch of GMK SpheriKA, which is the world's first kinematic alignment-optimized femoral component indicated for total knee replacement. Medacta Group S.A. is a Switzerland-based company offering personalized, innovative, and sustainable solutions for sports medicine, joint replacement, and spine surgeries.
The government's investment in research and development has considerably enhanced the knee replacement market. Government initiatives aim to reduce the cost of joint replacement surgeries by reforming the medical device regulations and providing subsidies for such surgeries have significantly boosted the market growth. Furthermore, tax exemptions and collaborations with prominent manufacturers have increased domestic output, lowering reliance on imports. These actions have increased the availability and affordability of knee replacement surgeries establishing specific countries as vital players in the knee replacement market, promoting economic growth and technical innovation in the health care sector.
For example, the Comprehensive Care for Joint Replacement (CJR) Model of the United States government is going to complete eight performance years (PYs) in December 2024. The program is a Medicare Part A and B payment model that aims to facilitate finances for patients with hip, knee, and ankle replacements, also called lower extremity joint replacements. The program has been a major success over the course of 8 years and is a good example of government initiatives to support the knee replacement market.
Total knee replacements have established their dominance with strong statistics in the market. Total knee replacement is one of the most effective and cost-efficient procedures for knee surgeries. It is most commonly done for patients suffering from highly painful, end-stage knee arthritis. Market data shows that there is a growing need for total knee replacement procedures owing to the growing geriatric population and decline in nutritional intake. Advancements in robotic-assisted surgeries and implant designing are anticipated to sustain the dominance of the total knee replacement segment within the knee replacement market.
For instance, in February 2023, as per the press release by CK Birla Hospital, Delhi, more than 2.5 lakh total knee replacement surgeries are performed in India every year, and the number has increased almost three times during the last five years.
The knee replacement market is becoming dominant in the North American region. The region is anticipated to dominate the market with the highest value share due to its significant investment in research and development, technical breakthroughs made by major market players, and highly developed healthcare infrastructure in North American countries like the United States and Canada. The market is expanding in the region because of encouraging government initiatives and a favorable reimbursement environment for handling the rising number of surgical procedures. Regulatory approvals and further market expansion are also beneficial to manufacturers. A growing number of knee surgeries is also contributing to the market growth. For instance, the American College of Rheumatology estimates that 790,000 knee operations are performed in the United States each year.
For instance, in April 2023, the USFDA approved the MISHA Knee System, manufactured by Moximed, Inc. for marketing in the United States. MISHA Knee System is an implant placed alongside the knee joint which helps in reducing the weight load and saving knee damage without removing the knee joint.
Growing prevalence of osteoporosis among the geriatric population and females is majorly driving the demand in the knee replacement market.
Rising geriatric population which is more prone to knee damage across the globe is drastically contributing to the knee replacement market.
Total knee replacement is the leading segment in the knee replacement market due to the high demand and volume of surgeries being performed.
Increasing adoption of surgical robotics for knee replacement surgeries as it offers reduced pain, fewer complications, and increased accuracy.
Key participants in the knee replacement market include: Zimmer Biomet Holdings Inc, B. Braun Melsungen AG, Smith & Nephew plc, Stryker Corporation, and Johnson & Johnson Services, Inc. characterizes this landscape, as these companies compete to outperform one another in terms of patient compliance, safety, accuracy, and unique features. The market prognosis remains positive, owing to increased demand for knee replacement surgeries. Knee replacement solution manufacturers are actively involved in designing innovative solutions. Collaborations and modern technologies are projected to increase competition in the market.
In March 2023, Stryker announced the launch of Mako Total Knee 2.0, at the AAOS 2023 annual meeting in Las Vegas. Mako Total Knee 2.0 is unveiled with new features like customizable workflow, intuitive design, innovative digital tensioner that allows surgeons to analyze the knee's stability during total knee arthroplasty without the need for further instrumentation. Mako Total Knee 2.0 has three key components, AccuStop haptic technology, 3D CT-based planning, and insightful data analytics.
In November 2023, Salona Global announced the launch of the Biodex SpaceTek Knee device, which is developed in collaboration with NASA to be used in space as well. Biodex SpaceTek Knee device is a revolutionary portable isokinetic knee dynamometer medical device for treating patients with knee replacements and knee injuries. The FDA approval for the product is still in progress.
All segments will be provided for all regions and countries covered:
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.